234 related articles for article (PubMed ID: 22120621)
1. Engineering bacteria toward tumor targeting for cancer treatment: current state and perspectives.
Lee CH
Appl Microbiol Biotechnol; 2012 Jan; 93(2):517-23. PubMed ID: 22120621
[TBL] [Abstract][Full Text] [Related]
2. Employment of Salmonella in Cancer Gene Therapy.
Lee CH
Methods Mol Biol; 2016; 1409():79-83. PubMed ID: 26846804
[TBL] [Abstract][Full Text] [Related]
3. Salmonella as an innovative therapeutic antitumor agent.
Chang WW; Lee CH
Int J Mol Sci; 2014 Aug; 15(8):14546-54. PubMed ID: 25196596
[TBL] [Abstract][Full Text] [Related]
4. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery.
Thorne SH; Contag CH
Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814
[TBL] [Abstract][Full Text] [Related]
5. Tumor-colonizing bacteria: a potential tumor targeting therapy.
Zu C; Wang J
Crit Rev Microbiol; 2014 Aug; 40(3):225-35. PubMed ID: 23964706
[TBL] [Abstract][Full Text] [Related]
6. Bacteria-mediated disease therapy.
Yu H
Appl Microbiol Biotechnol; 2011 Dec; 92(6):1107-13. PubMed ID: 22033568
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for cancer: bacteria-mediated anti-angiogenesis therapy.
Gardlik R; Behuliak M; Palffy R; Celec P; Li CJ
Gene Ther; 2011 May; 18(5):425-31. PubMed ID: 21228886
[TBL] [Abstract][Full Text] [Related]
8. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
Hoffman RM
Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
[TBL] [Abstract][Full Text] [Related]
9. Exploiting diversity: genetic approaches to creating highly potent and efficacious oncolytic viruses.
Bauzon M; Hermiston TW
Curr Opin Mol Ther; 2008 Aug; 10(4):350-5. PubMed ID: 18683099
[TBL] [Abstract][Full Text] [Related]
10. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
Sinkovics JG; Horvath JC
Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
[TBL] [Abstract][Full Text] [Related]
11. Attenuated bacteria as effectors in cancer immunotherapy.
Al-Ramadi BK; Fernandez-Cabezudo MJ; El-Hasasna H; Al-Salam S; Attoub S; Xu D; Chouaib S
Ann N Y Acad Sci; 2008 Sep; 1138():351-7. PubMed ID: 18837910
[TBL] [Abstract][Full Text] [Related]
12. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
Terada K; Wakimoto H; Tyminski E; Chiocca EA; Saeki Y
Gene Ther; 2006 Apr; 13(8):705-14. PubMed ID: 16421599
[TBL] [Abstract][Full Text] [Related]
13. The next frontier of oncotherapy: accomplishing clinical translation of oncolytic bacteria through genetic engineering.
Dailey KM; Allgood JE; Johnson PR; Ostlie MA; Schaner KC; Brooks BD; Brooks AE
Future Microbiol; 2021 Mar; 16(5):341-368. PubMed ID: 33754804
[TBL] [Abstract][Full Text] [Related]
14. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment.
Lemmon MJ; van Zijl P; Fox ME; Mauchline ML; Giaccia AJ; Minton NP; Brown JM
Gene Ther; 1997 Aug; 4(8):791-6. PubMed ID: 9338007
[TBL] [Abstract][Full Text] [Related]
15. Live bacteria as anticancer agents and tumor-selective protein delivery vectors.
Bermudes D; Zheng LM; King IC
Curr Opin Drug Discov Devel; 2002 Mar; 5(2):194-9. PubMed ID: 11926125
[TBL] [Abstract][Full Text] [Related]
16. Selectively replicating oncolytic adenoviruses as cancer therapeutics.
Yu DC; Working P; Ando D
Curr Opin Mol Ther; 2002 Oct; 4(5):435-43. PubMed ID: 12435044
[TBL] [Abstract][Full Text] [Related]
17. Bacterial targeted tumour therapy-dawn of a new era.
Wei MQ; Mengesha A; Good D; Anné J
Cancer Lett; 2008 Jan; 259(1):16-27. PubMed ID: 18063294
[TBL] [Abstract][Full Text] [Related]
18. The preclinical discovery of bacterial therapy for the treatment of metastatic cancer with unique advantages.
Hoffman RM
Expert Opin Drug Discov; 2012 Jan; 7(1):73-83. PubMed ID: 22468895
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiotherapy: emerging treatment improvement strategies.
Milas L; Mason KA; Liao Z; Ang KK
Head Neck; 2003 Feb; 25(2):152-67. PubMed ID: 12509799
[TBL] [Abstract][Full Text] [Related]
20. Engineering of bacterial strains and their products for cancer therapy.
Bernardes N; Chakrabarty AM; Fialho AM
Appl Microbiol Biotechnol; 2013 Jun; 97(12):5189-99. PubMed ID: 23644748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
